Total raised
$126.6M
Last: PIPE 2017-04
Stage
Acquired
Founded
2005
Headcount
8
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
SteadyMed Therapeutics Inc has developed the PatchPump platform to deliver injectable drugs. Using its proprietary ECell technology, the PatchPump is a customizable, prefilled, preprogrammed disposable parenteral (non-oral) delivery platform for large-volume and viscous formulations. The device attaches to the abdomen and delivers medicine through a small needle on an ongoing basis. SteadyMed's product will initially be focused on serving patients with pulmonary arterial hypertension and chronic pain.
Funding history · 6 rounds · $126.6M total
2017-04
PIPE
$30.0M
2016-07
PIPE
$32.0M
2015-01
Undisclosed
$12.2M
2013-04
Debt Financing
$3.0M
2012-09
Seed
$10.4M
2009-01
Pre-Seed
$2.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is SteadyMed Therapeutics' primary product or platform?
- SteadyMed Therapeutics developed the PatchPump platform, a customizable, prefilled, preprogrammed disposable parenteral delivery system for injectable drugs, utilizing its proprietary ECell technology.
- When was SteadyMed Therapeutics founded?
- SteadyMed Therapeutics was founded in June 2005.
- What was the outcome for SteadyMed Therapeutics in April 2018?
- In April 2018, SteadyMed Therapeutics was acquired by United Therapeutics Corporation for $216 million, leading to its inactive status.
- When did SteadyMed Therapeutics go public and on which exchange?
- SteadyMed Therapeutics completed an IPO in March 2015, listing on NASDAQ under the ticker STDY.
- What was SteadyMed Therapeutics' first recorded funding round?
- SteadyMed Therapeutics secured a Pre-Seed round of $2,000,000 in January 2009, with Samson Venture Partners as an investor.
- Which investors participated in SteadyMed Therapeutics' Seed round in September 2012?
- In September 2012, SteadyMed Therapeutics raised $10,400,000 in a Seed round, with Samson Venture Partners and KB Partners among the investors.
- What was the total amount raised by SteadyMed Therapeutics through all funding rounds?
- SteadyMed Therapeutics raised a total of $126,600,000 across all its funding rounds.
- Where is SteadyMed Therapeutics' headquarters located?
- SteadyMed Therapeutics' headquarters is located at 5 Oppenheimer St, Rehovot, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Sensing
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2CB2B
Tags
cardiovascularpulmonarymedical-technologiesdrug-deliverypharmaceuticalspumpsblood-pressuresensorspharma-companies